These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 38253958)
1. Increase in venous thromboembolism in SARS-CoV-2 infected lung tissue: proteome analysis of lung parenchyma, isolated endothelium, and thrombi. Lopuhaä BV; Guzel C; van der Lee A; van den Bosch TPP; van Kemenade FJ; Huisman MV; Kruip MJHA; Luider TM; von der Thüsen JH Histopathology; 2024 May; 84(6):967-982. PubMed ID: 38253958 [TBL] [Abstract][Full Text] [Related]
2. Higher prevalence of pulmonary macrothrombi in SARS-CoV-2 than in influenza A: autopsy results from 'Spanish flu' 1918/1919 in Switzerland to Coronavirus disease 2019. Burkhard-Koren NM; Haberecker M; Maccio U; Ruschitzka F; Schuepbach RA; Zinkernagel AS; Hardmeier T; Varga Z; Moch H J Pathol Clin Res; 2021 Mar; 7(2):135-143. PubMed ID: 33185036 [TBL] [Abstract][Full Text] [Related]
3. The Incidence of Venous Thromboembolism in Critically Ill Patients with SARS-CoV-2 Infection Compared with Critically Ill Influenza and Community-Acquired Pneumonia Patients: A Retrospective Chart Review. Boyd S; Sheng Loh K; Lynch J; Alrashed D; Muzzammil S; Marsh H; Masoud M; Bin Ihsan S; Martin-Loeches I Med Sci (Basel); 2022 Jun; 10(2):. PubMed ID: 35736350 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management. Manolis AS; Manolis TA; Manolis AA; Papatheou D; Melita H J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):12-24. PubMed ID: 32924567 [TBL] [Abstract][Full Text] [Related]
5. A Comparison of Thrombosis and Hemorrhage Rates in Patients With Severe Respiratory Failure Due to Coronavirus Disease 2019 and Influenza Requiring Extracorporeal Membrane Oxygenation. Doyle AJ; Hunt BJ; Sanderson B; Zhang J; Mak SM; Benedetti G; Breen KA; Camporota L; Barrett NA; Retter A Crit Care Med; 2021 Jul; 49(7):e663-e672. PubMed ID: 33861545 [TBL] [Abstract][Full Text] [Related]
6. Thromboembolic involvement and its possible pathogenesis in COVID-19 mortality: lesson from post-mortem reports. Dwiputra Hernugrahanto K; Novembri Utomo D; Hariman H; Budhiparama NC; Medika Hertanto D; Santoso D; Hogendoorn PCW Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1670-1679. PubMed ID: 33629337 [TBL] [Abstract][Full Text] [Related]
7. An animal model for venous thrombosis and spontaneous pulmonary embolism. Frisbie JH Spinal Cord; 2005 Nov; 43(11):635-9. PubMed ID: 15951743 [TBL] [Abstract][Full Text] [Related]
8. Increase of mast cells in COVID-19 pneumonia may contribute to pulmonary fibrosis and thrombosis. Wismans LV; Lopuhaä B; de Koning W; Moeniralam H; van Oosterhout M; Ambarus C; Hofman FN; Kuiken T; Endeman H; Mustafa DAM; von der Thüsen JH Histopathology; 2023 Feb; 82(3):407-419. PubMed ID: 36366933 [TBL] [Abstract][Full Text] [Related]
10. Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia. Grosse C; Grosse A; Salzer HJF; Dünser MW; Motz R; Langer R Cardiovasc Pathol; 2020; 49():107263. PubMed ID: 32784110 [TBL] [Abstract][Full Text] [Related]
11. Clinical, laboratory and immunohistochemical characterization of in situ pulmonary arterial thrombosis in fatal COVID-19. Quartuccio L; Sonaglia A; Casarotto L; McGonagle D; Di Loreto C; Pegolo E Thromb Res; 2022 Nov; 219():95-101. PubMed ID: 36152461 [TBL] [Abstract][Full Text] [Related]
12. Venous Thrombosis and SARS-CoV-2. Zdanyte M; Rath D; Gawaz M; Geisler T Hamostaseologie; 2022 Aug; 42(4):240-247. PubMed ID: 34879422 [TBL] [Abstract][Full Text] [Related]
13. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Edler C; Schröder AS; Aepfelbacher M; Fitzek A; Heinemann A; Heinrich F; Klein A; Langenwalder F; Lütgehetmann M; Meißner K; Püschel K; Schädler J; Steurer S; Mushumba H; Sperhake JP Int J Legal Med; 2020 Jul; 134(4):1275-1284. PubMed ID: 32500199 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohort. Ward A; Sarraju A; Lee D; Bhasin K; Gad S; Beetel R; Chang S; Bonafede M; Rodriguez F; Dash R PLoS One; 2022; 17(1):e0261786. PubMed ID: 35020742 [TBL] [Abstract][Full Text] [Related]
15. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra). Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052 [TBL] [Abstract][Full Text] [Related]
16. In Situ Pulmonary Arterial Thrombosis: Literature Review and Clinical Significance of a Distinct Entity. Baranga L; Khanuja S; Scott JA; Provancha I; Gosselin M; Walsh J; Arancibia R; Bruno MA; Waite S AJR Am J Roentgenol; 2023 Jul; 221(1):57-68. PubMed ID: 36856299 [TBL] [Abstract][Full Text] [Related]
17. Management, control, and decision making in unexpected recurrent venous thromboembolism in COVID-19: a case report. Zolfaghari Emameh R; Heshmatnia J J Med Case Rep; 2023 Mar; 17(1):101. PubMed ID: 36934279 [TBL] [Abstract][Full Text] [Related]
18. Fatal pulmonary thromboembolism in asymptomatic COVID-19. Keane G; Dorman T Ir J Med Sci; 2022 Aug; 191(4):1777-1783. PubMed ID: 34482482 [TBL] [Abstract][Full Text] [Related]
19. Extensive deep vein thrombosis and pulmonary embolism as a unique clinical manifestation of COVID-19 in a young healthy patient. Llausas-Villarreal A; Mendoza-Silva M; Gómez-Gutiérrez OA; Gonzalez-Urquijo M; Fabiani MA Vascular; 2022 Oct; 30(5):1013-1016. PubMed ID: 34416115 [TBL] [Abstract][Full Text] [Related]
20. Pulmonary Thrombosis and Thromboembolism in COVID-19. Poor HD Chest; 2021 Oct; 160(4):1471-1480. PubMed ID: 34153340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]